Edition:
India

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

83.55USD
23 Aug 2016
Change (% chg)

$-0.04 (-0.05%)
Prev Close
$83.59
Open
$83.84
Day's High
$84.59
Day's Low
$83.34
Volume
68,568
Avg. Vol
91,399
52-wk High
$89.16
52-wk Low
$60.02

CRL.N

Chart for CRL.N

About

Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company is engaged in the business of providing the research models required in research and development of new drugs, devices and therapies. The Company operates through three segments: Research Models and Services... (more)

Overall

Beta: 1.21
Market Cap(Mil.): $3,953.26
Shares Outstanding(Mil.): 47.29
Dividend: --
Yield (%): --

Financials

BRIEF-Charles River Labs Q2 earnings per share $0.73

Aug 3 Charles River Laboratories International Inc

03 Aug 2016

BRIEF-Charles River, Moderna Therapeutics announce strategic collaboration

June 6 Charles River Laboratories International Inc :

06 Jun 2016

U.S. RESEARCH ROUNDUP-Cirrus Logic, Lumentum Holdings, Scorpio Bulkers

May 5 Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Bruker Corp and Aircastle Ltd, on Thursday. HIGHLIGHTS * On Deck Capital Inc : Morgan Stanley cuts to equal weight from overweight * NXP Semiconductors NV :Goldman Sachs ups to buy * Cirrus Logic : Barclays cuts to equal weight from overweight * Lumentum Holdings Inc : JP Morgan raises to overw

05 May 2016

BRIEF-Charles river laboratories announces first-quarter 2016 results from continuing operations

May 4 Charles River Laboratories International Inc

04 May 2016

BRIEF-Charles River has committed to invest up to $10 mln in Biomotiv

April 13 Charles River Laboratories International Inc

14 Apr 2016

Earnings vs. Estimates